Find a specific notice:

A corrigendum to this notice was published on 13 April 2017, Issue No. 39, Notice No. 2017-go1832.

Notice Type
Departmental
Notice Title

Renewal of Provisional Consent to the Distribution of Medicines

Publication Date
26 Jan 2017

Tags

Medicines Act Renewal of provisional consent to the distribution of medicines Health

Notice Number

2017-go297

Issue Number

8
Title
View PDF
File Type and Size
PDF (21 KB)

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Proleukin
Aldesleukin 18MIU
Powder for injection
Novartis New Zealand Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany

Note: This renewed consent is valid for one year from 29 January 2017.

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Verorab
Rabies vaccine, Wistar PM/WI 38-1503-3M 2.5IU
Powder for injection
Sponser Name
Sanofi-aventis New Zealand Limited
Sanofi Pasteur SA, Val-De-Reuil Cedex, France
Sanofi Pasteur SA, Marcy L’Etoile, France

Note: This renewed consent is valid for one year from 27 January 2017.

Dated this 20th day of January 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).